Core Outcome Set Developers’ Response to COVID-19
Many clinical trials and systematic reviews are already underway, or will begin shortly, to strengthen the evidence base for the COVID-19 response. Core outcome sets (COS), showing the outcomes that should be measured and reported in these studies, will ensure that this evidence base will contain, as a minimum, the key information needed by decision makers about the effects of interventions. This briefing paper has been prepared by COMET to summarise work to date on COS for COVID-19 and the COMET team will try to respond to any queries you have about it. COMET will also facilitate contact with COS developers to help determine which COS may be most relevant to your particular research study.
Find the latest updates on COVID COS.
Other COS Literature
- Core Outcome Sets
- Core outcome sets and systematic reviews
- Developing core outcome sets for clinical trials: issues to consider
- Core Outcome Sets: What They Are & Their Relevance to Research and KT
Navigate the COVID-19 Research Implementation Hub themes
Key Member Hubs and Organisations
Ongoing Trials
The Global Health Network is maintaining a resource bank designed to aid in the tracking and identification of ongoing trials and studies concerning COVID-19. The bank also features resources which provide access to trial materials such as protocols, data sets and publications. You can access it here